T.Man Pharmaceutical PCL (BKK: TMAN)

Market Cap	5.60B
Revenue (ttm)	2.20B
Net Income (ttm)	433.28M
Shares Out	400.00M
EPS (ttm)	1.37
PE Ratio	10.25
Forward PE	10.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	651,794
Open	14.10
Previous Close	13.90
Day's Range	13.90 - 14.30
52-Week Range	13.90 - 19.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 4, 2025

About T.Man Pharmaceutical PCL

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health products. It offers a range of pharmaceutical products, including antibiotics, gastrointestinal drugs, respiratory drugs, musculoskeletal drugs, nervous system drugs, and chronic disease drugs, as well as medicines for the skin in form of tablets, capsules, powders, liquids, and semisolids. The company was incorporated in 2023 and is headquartered in Bangkok, Thailand.

• Industry: Pharmaceutical Preparations
• Founded: 2023
• Employees: 944
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: TMAN

Financial Performance

In 2023, T.Man Pharmaceutical PCL's revenue was 1.98 billion, a decrease of -2.20% compared to the previous year's 2.02 billion. Earnings were 431.09 million, a decrease of -8.77%.